Abstract
Full exploitation of microarray data requires hidden information that cannot be extracted using current analysis methodologies. We present a new approach, hidden variable dynamic modeling (HVDM), which derives the hidden profile of a transcription factor from time series microarray data, and generates a ranked list of predicted targets. We applied HVDM to the p53 network, validating predictions experimentally using small interfering RNA. HVDM can be applied in many systems biology contexts to predict regulation of gene activity quantitatively.
Background
In order to understand how gene networks function, it is necessary to identify their components and to quantitatively describe how they relate to one another [13]. Subsequent prediction of gene network behavior requires identification of important parameters and variables, and estimation or measurement of their values during a response [46].
Experimental approaches can be applied to identify network components. For example, protein binding arrays and chromosome immunoprecipitation can be applied to identify transcription factor (TF)binding sites and therefore infer TF targets [710]. However, these approaches give a static view of the system. Binding sites identified in vitro may not be available in vivo, and different regulators may be active in different cellular systems. Furthermore, purely experimental approaches cannot predict in a quantitative manner, and with statistical confidence, the dynamics of network activity without making an impractical number of experimental observations [11].
Insight into the dynamic relationships present in a transcriptional response can be gained by running time series of microarrays [3,11,12]. Currently, analysis of this type of datum chiefly relies on clustering or correlation methods. The assumption is that groups of genes with similar expression profiles over time are likely to be regulated by the same TF. Although clustering approaches have been applied with some success, they are limited and inaccurate. Genes with different profiles may still be regulated by the same TF, and many genes included in clusters may be regulated by other factors. Clustering approaches typically do not generate confidence statistics about the validity of individual predictions, and therefore they can neither rank candidates nor distinguish between true and false targets.
Importantly, because clustering is based on only the expression time profile, the influence of other important factors required to reconstruct gene network activity is not taken into account. For example, transcript degradation rates, the sensitivity of a gene to a TF (or affinity of binding to the promoter), and the activity of the TF itself all contribute to the overall transcriptional output. Where clustering methods alone are applied, these quantities remain hidden in the data and are likely to confound any attempted analysis. As a consequence, microarray experiments typically return a list of targets based on expression level alone, and prioritization of genes of interest depends chiefly on researcher intuition.
An alternative strategy is to use a mathematical model of the network dynamics to provide a framework for the analysis of the expression time profile. Several types of model have been applied at different levels of complexity ranging from parts lists to dynamic models [3,11,12]. In theory, modeling can be applied to reconstruct a gene network in a quantitative manner [3,11,13]. The advantage of such an approach is that all of the important mechanisms that affect transcript levels can be taken into account simultaneously. Statistical confidence intervals can then be calculated, which allow the prediction of transcriptional targets with a specified statistical significance. As a result it is possible to predict how network regulation would change in response to differing conditions, allowing the optimal targeting of expensive experimental approaches.
We therefore developed a mathematical approach that uses information from a dynamic microarray time series data set to estimate, with confidence intervals, key parameters and hidden variables, specifically TF activity profiles. We define TF activity in terms of the positive effect that the TF has on transcription of its targets. We chose as a model experimental system the transcriptional response to ionizing irradiation. Ionizing radiation induces DNA damage, which in turn activates the p53 response [14]. p53 is a transcription factor and tumor suppressor, but it is only one of several TFs activated by DNA damage [15,16].
Our analysis method allows quantitative prediction, with confidence, of transcripts that are upregulated by p53 in the complex response, without the need for very large numbers of experimental observations. We have made use of prior biologic information (known p53 targets) to construct a mathematical model of gene regulation, calculated confidence intervals using a highly efficient novel approach, and anchored the model by including a surprisingly small amount of additional biologic information. We show that the model outperforms a clustering approach in terms of accuracy of target prediction, and we successfully tested model predictions with a separate experimental data set.
Results
A model of transcription factordependent gene transcription
We grew and irradiated a human leukemia cell line (MOLT4) containing functional p53 and harvested protein and RNA at regular intervals after irradiation. The time course was performed in triplicate, and Affymetrix U133A microarrays (Affymetrix Inc., Santa Clara, CA, USA) were run to measure the global transcriptional response. Before irradiation, we assumed the p53 network to be in equilibrium (that is, that the rate of change in its constituents is zero). Irradiating the cells disrupts the equilibrium and activates transcription of numerous p53 target genes. The rate at which p53dependent mRNA transcripts accumulate depends on the basal transcription rate of a target gene, the sensitivity of the gene to p53, the level of activity of p53, and the transcript degradation rate. We can connect these factors to represent the overall behavior of the system. The time evolution of each gene transcript is described by the following nonautonomous linear differential equation for the rate of change in transcript concentration x_{j}(t) of gene j at time t:
Where B_{j }is the constant basal transcription rate of j; S_{j}f(t) is the transcription induced by p53, composed of a constant S_{j}, which is the sensitivity of gene j to p53, and f(t), which is the activity of p53 at time t; and D_{j}x_{j}(t) is a degradation term, with D_{j }being a constant degradation rate. For a full description of the model, see Mathematical methodology (below).
Deriving the hidden activity profile of p53
In order to predict whether a gene is likely to be a p53 target, it is necessary to estimate its sensitivity (S_{j}) to p53 and to ensure that parameter values can be found that, when combined in the model equation, result in an expression profile similar to the experimentally determined profile. However, the p53 activity f(t) is not experimentally available and is the key 'hidden variable' in the system. To estimate this profile we used prior biologic knowledge rather than adopting a 'black box' approach. We selected a small training set of five known p53 targets (DDB2, p21^{WAF1/CIP1}, SESN1/hPA26, BIK, and TNFRSF10b/TRAILreceptor 2) [1722] and used the microarray time series observations for this set to derive the p53 activity profile f(t), and the parameter values of basal transcription rate, sensitivity to p53, and degradation rate. These values and their confidence intervals were obtained by applying Markov Chain Monte Carlo (MCMC) with a MetropolisGibbs sampler [23] (see Mathematical methodology, below). Normally, the calculations involved in these estimations are very demanding on computer time. In terms of systems biology, in which many such calculations are likely to be linked, this poses a major barrier to network analysis. We therefore discretized the model equation and devised a fast matrixbased algorithm to solve it efficiently (see Mathematical methodology, below).
Initial estimates of the parameters and the hidden profile f(t) exhibited a very high degree of variance. Repeated modeling of artificial data indicated that this was a general characteristic of the model and not peculiar to the particular experimental data set. We noticed that the estimates were highly correlated with each other (Figure 1a). This suggested that experimentally determining the value of one additional parameter might constrain the others and so reduce the overall variance. We therefore measured the rate of degradation of one transcript (p21^{WAF1/CIP1}) using quantitative polymerase chain reaction (PCR; Figure 1b). We found that this single measurement was sufficient to reduce dramatically the variance and greatly improve the final estimates (Figure 1c). We term this process 'data anchoring'. We found that obtaining the degradation rate of any element in the training set was equally sufficient to anchor the model, provided that the same gene was also used as the reference point for estimating sensitivity (see Mathematical methodology, below). The inclusion of the degradation rates of more genes did not significantly improve parameter estimation.
Figure 1. Model based estimation of activity profile of p53. (a) Markov Chain Monte Carlo output for potential transcription factor activity profile values for first time series replicate at 4 hours (x axis) and 6 hours (y axis). (b) Concentration of p21^{WAF1 }transcript determined by realtime polymerase chain reaction after addition of actinomycin D (10 μg/ml) to irradiated (5 Gy, 4 hours) MOLT4 cells cultured in RPMI. Expressed as percentage of initial concentration. (c) Using the degradation rate of p21^{WAF1 }dramatically restricted the range of solutions to the Markov Chain Monte Carlo.
Incorporation of the degradation data allowed efficient estimation of the parameters B_{j}, S_{j }and D_{j}, and the p53 activity profile f(t) for the training set of known targets (Figure 2). This process was performed simultaneously on three replicate time series to improve the robustness of the outcome (Figure 2b). We found that the modelestimated profile approximated the experimentally determined activity profile based on measuring p53 phosphorylation at serine 15 [24] (Figure 3). The profiles show a close match early in the response, but the model predicts a more rapid decline in activity. This discrepancy can be explained by the operation of other regulatory mechanisms that affect p53 activity but not concentration, for example relocation of phosphorylated p53 to the cytoplasm [25].
Figure 2. Parameter estimation for a training set of five known p53 targets. (a) The model equation was solved to estimate values for the parameters basal transcription B_{j }sensitivity S_{j}, and degradation D_{j }for the five p53 targets DDB2, p21^{WAF1/CIP1}, SESN1/hPA26, BIK, and TNFRSF10b/TRAILreceptor 2. (b) Simultaneously, the activity profile f(t) of p53 was derived from three separate microarray time courses.
Figure 3. Experimentally determined p53 activity profile. The activity profile of p53 was measured by Western blot to determine the levels of ser15 phosphorylated p53 (ser15Pp53). ser15 phosphorylation is a measure of p53 activity. IR, ionizing radiation. IR, ionizing irradiation.
Optimization of the model
The use of a training set of known targets takes advantage of the fact that prior biologic knowledge exists for many TFs. Because the p53 response is well studied, we were able to examine the optimum model requirements. We found that three training genes are sufficient for the model to make accurate parameter estimates (Figure 4a). The inclusion of more (up to ten) genes narrowed the confidence intervals but the improvement was small beyond five genes. We also found that inclusion of genes not regulated by p53 (for example TNFSF10) led to a poor genespecific model score, enabling these genes to be excluded from the training set. We found the method to be very robust, and the exact choice of target genes does not appear to affect estimation greatly, providing that the measurement error is not excessive (namely, the detection P value should be below 0.001 for Affymetrix data) and that the anchoring gene is clearly differentially regulated (Figure 4b; also see Mathematical methodology, below).
Figure 4. Choice and number of training set genes does not significantly affect the predicted activity profile. (a) Predicted activity profile of p53 derived using different numbers of known targets in the training set, from three to ten genes. (b) Predicted activity profile of p53 derived using 100 combinations of three randomly selected training set genes from a pool of 10 known targets.
Prediction of p53 targets using hidden variable dynamic modeling
Once we had constructed the estimate for the key 'hidden variable', namely the p53 activity profile f(t), we were able to apply the model to the remaining expression data to predict p53 targets. Data was filtered to identify upregulated and detected genes (754 in total). These were then tested to determine how well they fitted the model of activation by p53. We derived a score M (> 0) based on the closeness of experimental data to model predictions (in which lower scores are better). Because nonchanging genes with a flat profile would also fit the model, another score was computed that captures the predicted sensitivity to p53. This sensitivity score is a measure of how significantly S_{j }differs from zero, represented by a Z score. Z scores are the distance between the observed value and the population mean in units of standard deviation, and are therefore a measure of estimation robustness. Z scores are inversely related to P values (see Materials and methods, below).
We ranked the model scores, first in terms of model fit and then on predicted sensitivity to p53. Three broad classes of upregulated genes could be discerned, the composition of which depending on the stringency of the M score and sensitivity Z score threshold applied. At thresholds of M < 100 and sensitivity Z > 2 (and degradation estimates limited to 0.1/hour < D_{j }< 5/hour), class 1 consisted of 237 genes that fitted the model well and exhibited high probability of p53 sensitivity, exemplified by LRMP and p53TG1 (Figure 5a,b). Class 1 genes were therefore most likely to include genes regulated by p53, with the probability of sensitivity being the key indicator. As expected, the five known targets composing the training set were found among the 20 highest scoring genes (ranked by decreasing sensitivity Z score), alongside other established p53 targets and genes not previously known to be p53 regulated (Table 1).
Figure 5. Hidden variable dynamic modeling screening of upregulated genes. Model predicted profile (red) and experimental expression profile (black) of typical genes representing two classes of model prediction (class 1 and class 2). (a) Class 1 genes with good model score (M < 100) and high sensitivity P value (sensitivity Z score > 2; for example LRMP). (b) Class 1 genes with atypical expression profiles (for example, p53TG1); this profile occurs because of a low predicted degradation rate. (c,d) Two class 2 genes with low model score (M > 100) but high sensitivity P value (sensitivity Z score > 2; for example, TNFSF10 and IER3).
Table 1. Top 50 genes predicted by hidden variable dynamic modeling to be p53 regulated, ranked by sensitivity Z score
Under the same thresholds, in a second class of 105 genes a relatively high sensitivity score was achieved despite a poor model fit, as in the case of TNFSF10 (TRAIL) and IER3 (Figure 5c,d). The model attempts to accommodate genes strongly regulated by factors other than p53 by varying degradation and sensitivity scores, which often results in apparently high sensitivity predictions. However, the poor overall model fit suggests that class 2 genes are either completely independent of p53 or exhibit more complex coregulation.
Genes in class 3 have either poor sensitivity or poor model score (M > 100, sensitivity Z < 2), or both. The majority of the 412 genes in this group are likely to be regulated independently from p53 in a manner that exhibits no similarity to the p53 activity profile. However, class 3 will also include genes that are p53 dependent but that are not distinguishable by the model.
Verification of model predictions using small interfering RNA to p53
To validate the predictions made by the model, we transfected MOLT4 cells with small interfering (si)RNA to p53 to deplete p53 protein to below control levels (Figure 6a) [26]. siRNAp53 substantially reduced ionizing irradiationinduced increases in the transcripts of three p53 target genes, namely HDM2, P21, and GADD45α (Figure 6b). We then ran microarrays to measure the effect of siRNAp53 on the transcriptional response to irradiation at the whole genome level. Validation was carried out at 4 hours to maximize the number of p53 targets and to minimize the inclusion of secondary targets. Data were filtered to identify those genes that were upregulated in both the time course and in the pSuper transfected control at 4 hours (see Materials and methods, below). This identified a total of 162 genes that were upregulated significantly by irradiation at 4 hours.
Figure 6. Small interfering (si)RNAp53 reduces p53 protein levels and transcription of p53 target genes. (a) Transfection of siRNAp53 reduces p53 protein levels below control values. (b) Realtime quantitative polymerase chain reaction measurement of three p53 target genes (GADD45α, p21, and HDM2) and a control gene (GAPDH) after transfection of siRNAp53 and irradiation. IR, ionizing irradiation.
To quantify sensitivity to siRNAp53 at the individual gene level, we computed new Z scores that measured the difference between genes upregulated by irradiation in control cells and those upregulated in siRNAp53 treated cells. For clarity, these are referred to as validation scores. The higher the validation score, the more effectively siRNAp53 eliminates change in transcript concentration, and so the more likely the gene is to be dependent on p53. Seventyfour of the 162 4hourupregulated genes were predicted by the model to be p53 targets because they fell into class 1 (M < 100 and sensitivity Z score > 2). Of these 74, 66 (90%) exhibited high (Z > 1) validation scores (namely sensitivity to siRNAp53), confirming that they are p53 targets (Figure 7a). This figure rises to 73 out of 74 (98%) if a lower sensitivity Z score threshold (> 0.5) is applied or falls to 39 out of 74 (53%) if the sensitivity Z score threshold is set at 3. Higher sensitivity Z score thresholds therefore result in greater accuracy but at the expense of identifying a lower proportion of the targets (Figure 7b). Sensitivity Z score correlated well with validation score, indicating that predicted rank of p53 targets reflected the strength of p53 regulation (Figure 7c).
Figure 7. Model validation. (a) Effect of small interfering (si)RNAp53 on irradiation (5 Gy) induced change in transcript levels at 4 hours of the 74 class 1 genes. (b) Effect of altering S_{j }Z score threshold for class 1 on proportion of true targets identified (% of p53 upregulated genes at 4 hours predicted; black line) and accuracy of class 1 predictions (percentage of predictions made that were verified by siRNAp53; red line). Accuracy and proportion of the data explained reveal an inverse relationship. (c) Individual comparison of the effect of siRNAp53 on 74 class 1 genes with the best M and p53 sensitivity S_{j }score, ranked by sensitivity. Bars represent the validation score, a Z score measuring the effectiveness of siRNAp53 on reducing postirradiation upregulation of transcript. Higher scores indicate effective blocking of the response.
Thirty upregulated (4 hours) genes fell into class 2 (M > 100 and sensitivity Z score > 2). As expected, the response of class 2 genes to siRNAp53 was divided. Fourteen genes, including TNFSF10 (TRAIL), remained unaffected by siRNAp53, showing them to be p53 independent/irradiation dependent. Sixteen class 2 genes were affected to some degree by the treatment, confirming predictions that this group included coactivated or corepressed genes such as IER3, which is known to be synergistically regulated by nuclear factorκB and p53 [27]. The remaining 58 upregulated (4 hours) genes fell into class 3, 34 of which were affected by siRNAp53.
Overall the Z score for S_{j }(sensitivity to p53) was a good discriminator for identifying p53 targets. The model was able to predict with confidence, and at high accuracy, 66 out of 115 (57%) genes verified as p53 targets at 4 hours, based on a sensitivity Z score threshold of 2. A further 16 class 2 genes exhibited evidence of coregulation, suggesting an explanation for 71% of the interpretable data. Many of the remaining class 3 targets were expressed at low levels, or exhibited low (> 1.5fold) levels of differential expression. This raises questions about their biologic significance, and suggests that the true success rate of hidden variable dynamic modeling (HVDM) is actually higher than reported above. A larger number of replicates would be required to be confident of the status of class 3 genes.
As seen for the validation data set, tightening thresholds (by choosing a higher sensitivity Z score) results in more confidence that the targets are regulated by p53 but at the cost of explaining a lower percentage of the data (Figure 7). When applied to the entire upregulated data set, HVDM can accurately predict a large number of p53 targets from a short time course without any further experimental input (Figure 8). These predictions included a number of genes not previously known to be p53 targets, including CD38, DENNdomain protein FLJ22457, CROT, GLS2, HERC5, ASCC3, LRMP, and CIKS/ACT1/TRAF3IP2 (Table 1). siRNA validation at an early time point (4 hours) indicates that these genes are most likely to be direct targets. CD38 is best known as a prognostic marker in the leukemia B cell lymphocytic leukemia (BCLL associated) with poor outcome. It functions as a powerful regulator of calcium dependent signaling via the generation of cyclic ADP ribose and NAADP+ (nicotinic acid adenine dinucleotide phosphate) Its regulation by p53 suggests a possible role for calciumdependent signaling in the DNA damage response.
Figure 8. Model performance. Distribution of 459 upregulated genes that pass degradation filter based on model score and predicted sensitivity to p53. S_{j }Z score = 3 and model = 100 thresholds are shown. A total of 115 Genes verified as p53 targets at 4 hours are shown in red.
Hidden variable dynamic modeling predicts p53 targets more accurately than does K means clustering
Since both HVDM and clustering approaches aim to identify TF targets, we compared our results with a typical clustering approach, namely K means clustering. From the 754 genes identified as upregulated by irradiation, HVDM generated a ranked list of predicted p53 targets based on model score and best sensitivity Z scores (Table 1). Fortyeight of the 50 highest ranked targets (96%) predicted by HVDM were confirmed by siRNA to be p53 targets. These 50 HVDM predicted target genes were divided by K means clustering between six of eight clusters, each with a distinct response profile (Figure 9). For example, the HVDM predicted target TP53TG1 has a late expression profile (cluster 1, Figure 9), along with seven other top 50 targets. This profile is quite different from the activation profile of p53 or its 'typical' correlated targets (Figure 5b). Only two genes were probably false positives.
Figure 9. K means clustering of upregulated genes based on expression values. A total of 754 upregulated genes were optimally grouped into eight K means clusters (C1 to C8). The 50 best hidden variable dynamic modeling predictions (Table 1) are split among six clusters (highlighted in yellow). Accurate prediction of p53 targets is therefore not possible using K means at this level.
K means clustering of the 754 detected and upregulated genes based on expression levels alone grouped the genes into eight clusters based on transcript time profile (Figure 9). Visual examination of the profiles suggested that one of these classes (cluster 7, Figure 9) was most similar to the p53 activity profile determined by Western blot (Figure 5b), and indeed this cluster contained many of the well known p53 targets (including GADD45α, p21, and DDB2). However, because clustering approaches typically do not provide confidence intervals, it is impossible to identify which genes within the cluster are most or least likely to be real targets. We found that 25 out of 79 genes in cluster 7 were verified as p53 targets in the siRNA experiment (32%; data not shown). Verified genes also occurred in cluster 1 (11 out of 135 (8%)), cluster 3 (35 out of 102 (34%)), cluster 4 (21 out of 120 (17.5%)), cluster 5 (3 out of 90 (3.3%)), and cluster 6 (20 out of 51 (39%)).
In summary, HVDM can generate an accurate list of p53 targets with different expression profiles, ranked by probability of sensitivity to p53. In contrast, although K means clustering generates clusters enriched or depleted in p53 targets, it fails to identify targets with different profiles, is unable to quantify the level of sensitivity of a gene to p53, and cannot distinguish between true and false p53 targets. We also assessed the performance of selforganizing maps (SOM) clustering, with a similar outcome. This is expected, given that all processes that cluster on expression profile alone are bound to suffer similar deficiencies. Predictions made by HVDM are therefore accurate, explain a significant proportion of true targets, give indications about potential for coregulation, and provide an excellent basis for prioritization of downstream bioinformatics and experimental analysis.
Discussion
We present here an approach based on a simple differential equation model that uses hidden information to partially reconstruct, with confidence intervals, the p53 target network. Our algorithm, which we term hidden variable dynamic modeling, operates on two levels. First, it offers a quantitative description of a TF output network at the genomic level. Second, it provides a practical resource to enable the prediction of targets and a probability based prioritization of array data for downstream analysis.
Mathematical modeling of gene networks has taken a variety of approaches [3,11,12]. At the genome level, topographic network reconstruction has been achieved using a variety of methods and data sources, including microarray data [1,2830]. In contrast, dynamic modeling has typically been limited to short pathways or feedback loops because of the complexity associated with estimating high dimensional models [11]. Some attempts to group network behavior into modules for dynamic modeling have been successful [13]. Others have attempted dynamic modeling of whole microarray data sets using differential equation models to derive transcriptional profiles [5,6,31]. However, these interesting studies stop short of calculating confidence intervals that take into account measurement error and variability [31,32]. Without these measurements, the reliability of the model cannot be assessed. Neither do they test predictions made by the model by experimentation.
Most microarray data are analyzed by subjecting them to various levels of statistical filtering to identify differences between two or more conditions. The resultant list of genes may then be segregated according to gene ontology using various tools designed for this purpose [33]. It is assumed that coregulation of genes with a particular ontology is of interest, but this may be misleading and certainly cannot predict targets of a particular TF. Correlation approaches that cluster genes that exhibit a similar time course expression profile are more successful [34], but they are often inaccurate and miss many genuine targets with a different profile. The advantage of our approach is that it can predict genes with any profile as targets of the same TF.
Complex data sets contain hidden information about gene regulatory networks [35]. It has also been suggested that the use of prior biologic knowledge can improve the reconstruction of genetic networks [36]. In generating our model, we used a small amount of knowledge about TF targets to derive the activity profile of p53 and then applied this to partially reconstruct the p53 target network. Our model makes the assumption that, given a short time course, much of the network behavior can be explained using linear modeling, and our verification experiment strongly supports this assertion (Table 1). However, it is likely that some genes respond to p53 in a nonlinear manner, for instance as a result of saturation and/or threshold effects. Future extensions of our model to include these terms may explain an even higher proportion of the behavior (work in progress). It should also be noted that the model would be unable to distinguish between TFs with identical activity profiles. Combination of HVDM with experimental approaches or other in silico methods such as the identification of TFbinding sites could help to resolve this issue [3739]. The current model is only able to account for direct effects of the controlling TF, which is reasonable for the short time course employed in our studies. Future modifications to the model will permit modeling of secondary effects, namely genes upregulated at late time points that may be targets of targets.
HVDM correctly predicted the majority of p53 targets, including all of the well known examples, directly from time series measurements of a complex response. HVDM was also able to identify, with associated probability, genes that had not previously been identified as p53 targets. Several previous studies have aimed to identify p53 target genes on a genome wide level using microarrays. Zhao and coworkers [22] identified p53 targets by using a Zn^{2+}inducible p53 construct containing a metallothionein promoter. In this case, the specific induction of p53 required the establishment of a complex and artificial in vivo system. p53 targets could not be directly extracted from ionizing irradiation or ultraviolet irradiation experiments alone. Also, targets induced in the artificial system differed significantly from those induced by ionizing irradiation or ultraviolet, indicating that simple artificial systems cannot replicate the behavior of complex activities during a physiologic response. In another approach, Kannan and coworkers [40] employed a temperature sensitive p53 to identify p53 dependent transcription and used cycloheximide to distinguish between primary and secondary targets. However, again, a complex artificial system was required. Furthermore, temperature and cycloheximide are both likely to affect the resultant transcription patterns, and because the data cannot be ranked the reliability of many targets would require additional experimental verification. HVDM has the advantage that ranked probability based target lists can be extracted from complex data without having to isolate each factor experimentally.
We observed that genes that were affected by siRNAp53 but not predicted by the model typically exhibited expression levels close to the detection threshold or low levels of differential regulation, or were poorly hybridizing alternative probe sets for genes already predicted by the model to be targets. The biologic significance of many apparent targets not identified by the model is therefore questionable. The ability to provide ranked lists of predicted (class 1) targets with a high degree of confidence, and based on the minimum of input data, will allow researchers to make optimal use of their resources. Such prioritization has been lacking in microarray data analysis and has hampered the efficient interpretation of array experiments.
It is important to note that the model is dynamic. It not only identifies targets but also predicts network behavior in response to changing conditions or altered parameters. For example, treatment with a drug that alters p53 activity could potentially be modeled entirely in silico based on its effects on expression of the training set of target genes. This may have implications for predicting the consequence of clinical or experimental treatments [41].
Conclusion
We addressed the problem of extracting hidden information from time series microarray data. We present a method that models the p53 target network following DNA damage, in which we use prior biologic information (a training set) to construct a mathematical model of the transcriptional response to DNA damage in MOLT4 cells. We have also developed a method to calculate confidence intervals for parameter estimates in a highly efficient manner. We found that the inclusion of a surprisingly small amount of additional biologic information was necessary to anchor the model. Most importantly, we then successfully tested the model predictions with an entirely separate experimental data set.
Our model accurately predicted a significant proportion of transcriptional targets of p53 and explained their behavior. The model identified genes not previously known to be p53 regulated, and it is more widely applicable and more accurate than correlation or clustering methods because it considers degradation rates as well as transcript accumulation profiles. Furthermore, HVDM can extract hidden information from small data sets in which experimental methods would require an impractical number of observations. Finally, HVDM allows the probabilitybased prioritization of microarray data, permitting researchers to exclude irrelevant information and rapidly focus on the networks of interest.
HVDM can be applied to any large time series data set in which identification of hidden variables can reveal critical information about network dynamics. The approach is quantitative and predictive, and demonstrates that combining mathematical modeling with experimental observations can help to unravel complex relationships in biologic systems.
Materials and methods
Biological methods
Cell lines and reagents
Human MOLT4 cells (T cell acute lymphoblastic leukaemia) were obtained from the National Institute for Biological Standards and Controls (Potters Bar, Herts, K; CFARP011) and cultured in RPMI, 10% fetal calf serum and Lglutamine, plus antibiotics. p53 genotype was determined by sequencing to verify wildtype status. p53 accumulation was monitored after irradiation by quantitative Western blotting, and regulation of known p53 targets (p21, GADD45α, and MDM2) following p53 activation by ionizing radiation was established to confirm p53 wildtype behavior (data not shown). Western blots were probed against total p53 (Santa Cruz Biotechnology Inc. Santa Cruz, CA, USA), phosphop53 (Cell Signalling Technologies, Danvers, MA, USA), and actin (Santa Cruz). Proteins were detected using enhanced chemiluminescence (ECL+; GE Healthcare, Chalfont St Giles, Bucks, UK) and quantified by densitometry.
Microarray time course
Cells in log phase (1 × 10^{6}/ml) were γirradiated with 5 Gy at room temperature at a dose rate of 2.45 Gy/minute with a ^{137}Cs γirradiator. Cells were harvested at 0, 2, 4, 6, 8, 10 and 12 hours, and RNA and protein were extracted (Trizol; Invitrogen, Paisley, UK). RNA and cRNA quantity and quality were determined by Nanodrop spectophotometer and Bioanalyser 2100 (Agilent, Wokingham, Berks, UK). Affymetrix U133A arrays (Affymetrix, Sanat Clara, CA, USA) were hybridized as standard. Array quality was determined using R and GCOS .rpt file values. The time course was replicated three times from independent cell preparations.
Microarray data analysis
Microarray data were summarized using the MAS5.0 algorithm (Affymetrix). Signal distribution was assessed using Genespring 6.1 (Agilent), and data were normalised to the median and log transformed for further analysis. For modeling applications, rescaled MAS5.0 data were analyzed using C code [42] (see Mathematical methodology, below). Data are available in MAGEML format via ArrayExpress (European Bioinformatics Institute) or on request.
Prediction of p53 targets
Data were filtered to identify 754 genes that were confidently upregulated by ionizing radiation (but not necessarily by p53) in at least one time point, and to exclude control genes (for example, spike ins). We excluded genes predicted to have a biologically impossible degradation rate (either close to zero (< 0.01/hour) or with too short a halflife (rate > 5/hour)). Next, we calculated the sum M of weighted differences between the model predicted profile and the experimentally determined transcript profile. Finally, the confidence that the transcript was sensitive to p53 activation was assessed by determining the probability that each individual sensitivity S_{j }was equal to 0. The modeling and statistical techniques used to compute these indicators are described extensively below.
Realtime quantitative polymerase chain reaction
MOLT4 cells were irradiated with 5 Gy and incubated at 37°C for various time periods. First strand cDNA was prepared (Invitrogen) and used as a template in PCR reactions with predeveloped target assays (Applied Biosystems, Foster City, CA, USA): p21, HDM2, GADD45, and GAPDH. Target and reference were amplified in separate wells in a 96well setup with three replicates for each reaction on ABI Prism SDS 7000 (Applied Biosystems), using default cycling conditions. Change in gene expression was calculated using 2^{dCT}, where dC_{T }is the mean of C_{T }(threshold cycle number) values obtained from the triplicate samples at each time point.
Small interfering RNA experiments
Cells were transfected with siRNAp53 (DNAEngine, Oligoengine, Seattle, WA, USA) or the vectoronly control (pSuper, Oligoengine), together with a marker plasmid (pcDNAneoGFP) using electroporation. GFPpositive cells (4050%) were sorted 24 hours after transfection on a MoFlo FACS sorter (Cytomation, Fort Collins, CO, USA) to a purity in excess of 98%. Fortyeight hours later sorted cells were irradiated with 5 Gy or mock irradiated and incubated for 4 hours at 37°C. RNA and protein were then prepared and processed for realtime quantitiative PCR, protein analysis, and microarray. For verification, data was filtered to include genes detected (Affymetrix P < 0.04 at t = 4 hours) and changed (Z score > 1) at 4 hours in both the time course and in the pSuper control, and to remove genes whose siRNAp53 call was caused mainly by differences in basal transcription levels (removing 28 out of 190 genes).
Mathematical methods
Model formulation
We assume that the transcript concentration x_{j}(t) of gene j satisfies the following timedependent linear differential equation:
This assumes that the transcript is degraded proportionally to its concentration, with the degradation rate D_{j}. The production term B_{j }+ S_{j}f(t) comprises a basal transcription rate B_{j}, which may be increased proportionally by the TF activity f(t). S_{j }is the sensitivity of gene j to that TF. Our overall aim is to estimate the parameters B_{j}, S_{j}, and D_{j }from the microarray data [_{j}(t_{i})], and in particular the sensitivity S_{j}. If S_{j }is not significantly greater than zero, then gene j is not regulated by the TF, whereas if S_{j }is large and significantly different from zero then the TF has a very strong effect on that gene.
The activity level f(t) of the TF (p53) is unknown. In order to estimate the hidden variable f(t), we need to parametrize the function f and estimate the resulting parameters. This raises the problem that if we try to estimate the unknown parameters in Equation 1 for single gene j, then we have more unknown parameters than we have data points. The unknowns are the three parameters B_{j}, S_{j}, D_{j}, and the n + 1 values f(t_{0}) ... f(t_{n}), as compared to the n + 1 observed data points _{j}(t_{0}) ... _{j}(t_{n}). (The term _{j }is the experimental measurements of gene j, composed of x_{j }+ ε, where ε is the measurement error.)
We observed that the equations for different genes are coupled by the level f(t) of the TF. Thus if we measure m genes simultaneously with microarrays, then we have m(n + 1) measurements _{j}(t_{i}) for j = 1 ... m and i = 0 ... n, but there are only 3 m + n + 1 unknowns B_{j}, S_{j}, D_{j }for j = 1 ... m and f(t_{0}) ... f(t_{n}). If the number of time points n is sufficiently large, then m(n + 1) = 3 m + n + 1, and we are able to estimate the unknowns using standard optimization methods. In practice we applied the model to replicate measurements that requires a modification to this approach (see Additional data file 1).
As the model stands, different parameter combinations could give rise to identical solutions for x_{j}(t). This is because both the origin and the scaling of the unobserved TF activity are arbitrary. Suppose that f(t) = α(t) + β for some constants α ≠ 0 and β. Then Equation 1 becomes the following:
Where _{j }= B_{j }+ S_{j}β and = αS_{j}. Because the TF is not observed, we have no way to distinguish between the models in Equation 1 and Equation 2. To overcome this ambiguity, we first set S_{j }= 1 for one gene, in our case p21. This fixes α and removes the ambiguity from the remaining S_{j }and reduces by one the total number of parameters to be estimated. Second, we assume that at the start of the experiment the activity level of the TF is 0. In other words, we set f(t_{0}) = 0, which is sufficient to fix β and hence remove the ambiguity from the B_{j}. It further reduces the parameter count by one.
Setting f(t_{0}) = 0 has the effect of defining the basal transcription rate B_{j }for each gene as the rate at the start of the experiment. We assume that the p53 network is in equilibrium before irradiation, and hence B_{j }can be thought of as the equilibrium transcription rate. Similarly, f can be interpreted as the deviation from equilibrium of the transcription factor activity.
Discretizing the model
In a systems biology context it is necessary to screen thousands of potential targets. We therefore developed a very rapid numerical method for estimating parameters in Equation 1.
Since Equation 1 is linear, it is possible to obtain an analytic solution:
We found that parameter estimation by direct application of standard numerical schemes for the evaluation of integrals was too slow. These approaches also suffer from the requirement to define an appropriate functional form and parametrization of f(t).
Instead, motivated by collocation based approaches to boundary value problems for nonlinear differential equations, we chose to discretize the model directly, converting the problem into an algebraic one. We illustrate this approach using the simplest possible discretization scheme.
To estimate the parameters in Equation 1 we must evaluate the derivative, which we denote Δ_{i}, on the left hand side at a specific time point t_{i}. Knowing the values x_{j}(t_{i1}), x_{j}(t_{i}), and x_{j}(t_{i+1}) at neighboring points, we computed the slope of x_{j}(t) between t_{i1 }and t_{i}, and the slope between t_{i }and t_{i+1}. We then combined these two values using an appropriate weighting and obtained an estimate for Δ_{i }(for notational convenience we define x_{i }= x_{j}(t_{i1})). If the time intervals are regular, so that t_{i } t_{i1 }= t_{i+1 } t_{i}, then:
This is equivalent to fitting a quadratic polynomial to the three points, and then evaluating its derivative at t_{i}. Higher order approximations can be obtained by using more points and fitting an appropriate polynomial. A suitable way of doing this is Lagrange interpolation [42]. This gives an explicit formula for a degree q  1 polynomial P(t) passing through the q points (t_{p}, x_{p}) ... (t_{i}, x_{i}) ... (t_{r}, x_{r}), where r = p + q  1:
Where
We call such an approximation a qpoint approximation (so that the example above gives a threepoint approximation). An approximation of the required derivative Δ_{i }can now be obtained by differentiating P(t) at t_{i}.
The right hand side is a linear function of x_{0 }... x_{n}. We shall denote the coefficients of this by A_{ik}, so that:
Where we set A_{ik }= 0 for k < p or k > r. (For a detailed calculation of A_{ik}, see 1.) We can then collate these various coefficients into a (n + 1) × (n + 1) matrix A. If we define the (n + 1) vectors as follows:
x_{j }= [x_{j}(t_{0}) ... x_{j}(t_{n})] = (x_{0 }... x_{n})
f = [f(t_{0}) ... f(t_{n})] = (f_{0 }... f_{n})
1 = (1 ... 1)
Then our approximation of Equation 1 can then be written as follows:
Ax_{j }= B_{j}1 + S_{j}f  D_{j}x_{j } (6)
The formal solution is given by
x_{j }= (A + D_{j}I)^{1}(B_{j}1 + S_{j}f)
Where I is the (n + 1) × (n + 1) identity matrix. In practice we solve Equation 6 using the LoewrUpper decomposition [42] of (A + D_{j}I).
Our approach to the solution of Equation 1 is several orders of magnitude faster than a naïve approach to solving the differential equation using an explicit fourth order RungeKutta, with the typical step size that would be employed in such a case. It also has the advantage that it is not necessary to specify a functional form for f(t). In our case f(t) is simply represented by the discrete set of values (f_{0 }... f_{n}), that is by the vector f.
Although our approach implicitly integrates the differential equation using large step sizes (effectively t_{i+1 } t_{i}), the unavoidable errors associated with estimating f(t) swamp any advantage gained by using smaller steps, and consequently there is no loss of accuracy in replacing Equation 1 by Equation 6. We validated this conclusion by generating artificial data and adding Gaussian noise of similar amplitude to that generally seen in microarray data. We found that the error in the parameter estimation induced by this noise overshadows the discretization error.
Model fitting
We employed the discretized model described in Equation 6 in two different ways. First, to estimate the TF profile f(t), we fit a microarray time series to a training set of five genes known to depend on p53 (DDB2, p21^{WAF1/CIP1}, SESN1/hPA26, BIK, and TNFRSF10b/TRAILreceptor 2). In order to do this, we also needed to estimate the parameters B_{j}, S_{j}, and D_{j }for these genes, although the estimated values are of no direct interest. We call the estimated profile obtained from this phase = (_{0 }... _{n}). We then used the estimated profile and applied the model to the transcription time series [_{j}(t_{0}) ... _{j}(t_{n})] for each gene j in our data set to estimate B_{j}, S_{j}, and D_{j}.
In each phase we employed a standard approach to fitting the unknown parameters. We define a candidate parameter vector, which in the first phase is given by the following equation:
μ = (B_{1 }... B_{m}, S_{1 }... S_{m}, D_{1 }... D_{m}, f_{0 }... f_{n})
In the second phase it is given by:
μ_{j }= (B_{j}, S_{j}, D_{j})
Equation 6 was solved for this set of parameters using the LU decomposition of (A + D_{j}I). In the first phase f = (f_{0 }... f_{n}), with the f_{i }taken from the candidate parameter vector μ. In the second phase we used = (_{1 }... _{m}) obtained from the first phase. We then computed the error M_{j }(depending on μ or μ_{j}, respectively) for each gene between the model solution and the actual data:
We assume the measurement errors to be independent and normally distributed with standard deviation σ_{j}(t_{i}) for the observation at time t_{i }of gene j. The calculation of σ_{j}(t_{i}) is detailed in Additional data file 1.
In the first phase the error over the training set (containing m genes) is then
To fit the model, we then varied μ or μ_{j }in a systematic way to find the parameters that make M or M_{j }as small as possible using a MCMC method [23]. This has the added advantage of also providing confidence intervals for the resulting parameter estimates. We assume that the measurement errors are Gaussian, giving a likelihood function proportional to exp (M/2) or exp(M_{j}/2). A MetropolisGibbs sampler was then applied with this likelihood. Because neither B_{j }nor D_{j }can take negative values, the MCMC sampling was carried out in logarithmic space for these two parameters [(og(B_{j}) and log(D_{j}), respectively).
To improve the convergence speed of the MCMC scheme it is advantageous to make jumps in the parameter space that are commensurate with the different parameter scales. This is particularly the case in the first phase, in which the dimensionality of the parameter space is high. We estimated such scales by running partial MCMC schemes on each group of parameters in turn, before running the full MCMC scheme. Specifically, parameters were grouped into four sets: degradation, transcription, basal rates, and TF profile. For each set a scale was determined to achieve an acceptance rate of approximately 25%. A final tuning run was carried out on the whole parameter set in order to achieve the prescribed acceptance rate of 25%. The main MCMC was seeded with the minimum of M found from a standard optimization procedure (the NelderMead simplex algorithm). A burn in of 10,000 iterations was applied before proper sampling. The final sample of 10,000 observations was extracted at random from the 10^{7 }iterations following burn in. We verified that these choices yielded good convergence.
In the second phase, in which the TF profile is known and there are only three parameters to determine, a long iteration run is unnecessary. We found that 10^{5 }iterations were sufficient to produce good convergence. Once again 10,000 observations randomly sampled from those iterations were used to compute the relevant statistics.
Additional data files
The following additional data are included with the online version of this article: A Word document giving details of the rescaling of array data, derivation of the coefficients of the differential operator, extension of model fitting to replicate measurements, and estimation of the measurement error (Additional data file 1).
Additional data file 1. A Word document giving details of the rescaling of array data, derivation of the coefficients of the differential operator, extension of model fitting to replicate measurements, and estimation of the measurement error
Format: DOC Size: 199KB Download file
This file can be viewed with: Microsoft Word Viewer
Acknowledgements
The ARP011 MOLT4 cell line was provided by NIBSC/CFAR through the EU Programme EVA/MRC Centralised Facility for AIDS Reagents, UK (grant Number QLK2CT199900609 and GP 828102). MB and DT are supported by postdoctoral fellowships from the BBSRC. DB holds a CHRAT studentship at ICH. We thank Lola Martinez for FACS sorting and Nipurna Jina for assistance with microarrays. This work was funded by the BBSRC as part of the Exploiting Genomics initiative.
References

Gardner TS, di Bernardo D, Lorenz D, Collins JJ: Inferring genetic networks and identifying compound mode of action via expression profiling.
Science 2003, 301:102105. PubMed Abstract  Publisher Full Text

Sontag E, Kiyatkin A, Kholodenko BN: Inferring dynamic architecture of cellular networks using time series of gene expression, protein and metabolite data.
Bioinformatics 2004, 20:18771886. PubMed Abstract  Publisher Full Text

Stark J, Brewer D, Barenco M, Tomescu D, Callard R, Hubank M: Reconstructing gene networks: what are the limits?
Biochem Soc Trans 2003, 31:15191525. PubMed Abstract  Publisher Full Text

Ronen M, Rosenberg R, Shraiman BI, Alon U: Assigning numbers to the arrows: parameterizing a gene regulation network by using accurate expression kinetics.
Proc Natl Acad Sci USA 2002, 99:1055510560. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

Chen HC, Lee HC, Lin TY, Li WH, Chen BS: Quantitative characterization of the transcriptional regulatory network in the yeast cell cycle.
Bioinformatics 2004, 20:19141927. PubMed Abstract  Publisher Full Text

Chang WC, Li CW, Chen BS: Quantitative inference of dynamic regulatory pathways via microarray data.
BMC Bioinformatics 2005, 6:44. PubMed Abstract  BioMed Central Full Text  PubMed Central Full Text

Lee TI, Rinaldi NJ, Robert F, Odom DT, BarJoseph Z, Gerber GK, Hannett NM, Harbison CT, Thompson CM, Simon I, et al.: Transcriptional regulatory networks in Saccharomyces cerevisiae.
Science 2002, 298:799804. PubMed Abstract  Publisher Full Text

Mukherjee S, Berger MF, Jona G, Wang XS, Muzzey D, Snyder M, Young RA, Bulyk ML: Rapid analysis of the DNAbinding specificities of transcription factors with DNA microarrays.
Nat Genet 2004, 36:13311339. PubMed Abstract  Publisher Full Text

Harbison CT, Gordon DB, Lee TI, Rinaldi NJ, Macisaac KD, Danford TW, Hannett NM, Tagne JB, Reynolds DB, Yoo J, et al.: Transcriptional regulatory code of a eukaryotic genome.
Nature 2004, 431:99104. PubMed Abstract  Publisher Full Text

Hall DA, Zhu H, Zhu X, Royce T, Gerstein M, Snyder M: Regulation of gene expression by a metabolic enzyme.
Science 2004, 306:482484. PubMed Abstract  Publisher Full Text

Stark J, Callard R, Hubank M: From the top down: towards a predictive biology of signalling networks.
Trends Biotechnol 2003, 21:290293. PubMed Abstract  Publisher Full Text

Schlitt T, Brazma A: Modelling gene networks at different organisational levels.
FEBS Lett 2005, 579:18591866. PubMed Abstract  Publisher Full Text

Kholodenko BN, Kiyatkin A, Bruggeman FJ, Sontag E, Westerhoff HV, Hoek JB: Untangling the wires: a strategy to trace functional interactions in signaling and gene networks.
Proc Natl Acad Sci USA 2002, 99:1284112846. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

Fei P, ElDeiry WS: P53 and radiation responses.
Oncogene 2003, 22:57745783. PubMed Abstract  Publisher Full Text

Jen KY, Cheung VG: Transcriptional response of lymphoblastoid cells to ionizing radiation.
Genome Res 2003, 13:20922100. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

Stankovic T, Hubank M, Cronin D, Stewart GS, Fletcher D, Bignell CR, Alvi AJ, Austen B, Weston VJ, Fegan C, et al.: Microarray analysis reveals that TP53 and ATMmutant BCLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses.
Blood 2004, 103:291300. PubMed Abstract  Publisher Full Text

Li CQ, Robles AI, Hanigan CL, Hofseth LJ, Trudel LJ, Harris CC, Wogan GN: Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wildtype or mutant p53.
Cancer Res 2004, 64:30223029. PubMed Abstract  Publisher Full Text

Marko NF, Dieffenbach PB, Yan G, Ceryak S, Howell RW, McCaffrey TA, Hu VW: Does metabolic radiolabeling stimulate the stress response? Gene expression profiling reveals differential cellular responses to internal beta vs. external gamma radiation.
FASEB J 2003, 17:14701486. PubMed Abstract  Publisher Full Text

Qian H, Wang T, Naumovski L, Lopez CD, Brachmann RK: Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
Oncogene 2002, 21:79017911. PubMed Abstract  Publisher Full Text

Rieger KE, Chu G: Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells.
Nucleic Acids Res 2004, 32:47864803. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

VelascoMiguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, Laidlaw J, Seizinger B, Kley N: PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes.
Oncogene 1999, 18:127137. PubMed Abstract  Publisher Full Text

Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ: Analysis of p53regulated gene expression patterns using oligonucleotide arrays.
Genes Dev 2000, 14:981993. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

Gilks WR, Richardson S, Spiegelhalter DJ: Markov Chain Monte Carlo in Practice. London: Chapman & Hall/CRC; 1995.

Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, et al.: Enhanced phosphorylation of p53 by ATM in response to DNA damage.
Science 1998, 281:16741677. PubMed Abstract  Publisher Full Text

Li M, Brooks CL, WuBaer F, Chen D, Baer R, Gu W: Mono versus polyubiquitination: differential control of p53 fate by Mdm2.
Science 2003, 302:19721975. PubMed Abstract  Publisher Full Text

Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells.
Science 2002, 296:550553. PubMed Abstract  Publisher Full Text

Schafer H, Diebel J, Arlt A, Trauzold A, Schmidt WE: The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.
FEBS Lett 1998, 436:139143. PubMed Abstract  Publisher Full Text

Basso K, Margolin AA, Stolovitzky G, Klein U, DallaFavera R, Califano A: Reverse engineering of regulatory networks in human B cells.
Nat Genet 2005, 37:382390. PubMed Abstract  Publisher Full Text

di Bernardo D, Thompson MJ, Gardner TS, Chobot SE, Eastwood EL, Wojtovich AP, Elliott SJ, Schaus SE, Collins JJ: Chemogenomic profiling on a genomewide scale using reverseengineered gene networks.
Nat Biotechnol 2005, 23:377383. PubMed Abstract  Publisher Full Text

Isalan M, Lemerle C, Serrano L: Engineering gene networks to emulate Drosophila embryonic pattern formation.
PLoS Biol 2005, 3:e64. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

Lin LH, Lee HC, Li WH, Chen BS: Dynamic modeling of cisregulatory circuits and gene expression prediction via crossgene identification.
BMC Bioinformatics 2005, 6:258. PubMed Abstract  BioMed Central Full Text  PubMed Central Full Text

Siggia ED: Computational methods for transcriptional regulation.
Curr Opin Genet Dev 2005, 15:214221. PubMed Abstract  Publisher Full Text

AlShahrour F, DiazUriarte R, Dopazo J: FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes.
Bioinformatics 2004, 20:578580. PubMed Abstract  Publisher Full Text

Remondini D, O'Connell B, Intrator N, Sedivy JM, Neretti N, Castellani GC, Cooper LN: Targeting cMycactivated genes with a correlation method: detection of global changes in large gene expression network dynamics.
Proc Natl Acad Sci USA 2005, 102:69026906. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

Liao JC, Boscolo R, Yang YL, Tran LM, Sabatti C, Roychowdhury VP: Network component analysis: reconstruction of regulatory signals in biological systems.
Proc Natl Acad Sci USA 2003, 100:1552215527. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

Le Phillip P, Bahl A, Ungar LH: Using prior knowledge to improve genetic network reconstruction from microarray data.
In Silico Biol 2004, 4:335353. PubMed Abstract

Elkon R, RashiElkeles S, Lerenthal Y, Linhart C, Tenne T, Amariglio N, Rechavi G, Shamir R, Shiloh Y: Dissection of a DNAdamageinduced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis.
Genome Biol 2005, 6:R43. PubMed Abstract  BioMed Central Full Text  PubMed Central Full Text

Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J: The p53MH algorithm and its application in detecting p53responsive genes.
Proc Natl Acad Sci USA 2002, 99:84678472. PubMed Abstract  Publisher Full Text  PubMed Central Full Text

Wang L, Wu Q, Qiu P, Mirza A, McGuirk M, Kirschmeier P, Greene JR, Wang Y, Pickett CB, Liu S: Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches.
J Biol Chem 2001, 276:4360443610. PubMed Abstract  Publisher Full Text

Kannan K, Amariglio N, Rechavi G, JakobHirsch J, Kela I, Kaminski N, Getz G, Domany E, Givol D: DNA microarrays identification of primary and secondary target genes regulated by p53.
Oncogene 2001, 20:22252234. PubMed Abstract  Publisher Full Text

Hood L, Heath JR, Phelps ME, Lin B: Systems biology and new technologies enable predictive and preventative medicine.
Science 2004, 306:640643. PubMed Abstract  Publisher Full Text

Press W, Teukolsky SA, Vetterling W, Flannery B: Numerical Recipes in C. Cambridge: Cambridge University Press; 1992.

Comander J, Natarajan S, Gimbrone MA Jr, GarciaCardena G: Improving the statistical detection of regulated genes from microarray data using intensitybased variance estimation.
BMC Genomics 2004, 5(1):17. PubMed Abstract  BioMed Central Full Text  PubMed Central Full Text

Kamb A, Ramaswanni M: A simple method for statistical analysis of intensity differences in microarrayderived gene expression data.
BMC Biotechnol 2001, 1(1):8. PubMed Abstract  BioMed Central Full Text  PubMed Central Full Text

Rocke DM, Durbin B: A model for measurement error for gene expression arrays.
J Comput Biol 2001, 8(6):557569. PubMed Abstract  Publisher Full Text

Mutch DM, Berger A, Mansourian R, Rytz A, Roberts MA: The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data.
BMC Bioinformatics 1992, 3(1):17. BioMed Central Full Text